MedPath

Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery

Phase 4
Withdrawn
Conditions
Post Operative Pain
Interventions
Registration Number
NCT03877549
Lead Sponsor
Henry Ford Health System
Brief Summary

This study will evaluate the ability of dexamethasone to enhance labor epidurals when administered as an adjunct to local anesthetics via an epidural catheter. Patients undergoing elective cesarean sections will be randomized into three groups, each receiving the same combined spinal epidural (CSE). At surgical closure, Group 1 will receive 10cc bupivacaine 0.0625%, Group 2 will receive 10cc bupivacaine 0.0625% +4mg dexamethasone, and Group 3 will receive 10cc bupivacaine 0.0625% + 8mg dexamethasone (4mg). VAS, sedation, nausea, and satisfaction scoring will be measured on patient follow-up to compare the outcomes of the different treatment groups.

Detailed Description

This study will evaluate the ability of dexamethasone to enhance labor epidurals when administered as an adjunct to local anesthetics via an epidural catheter. Patients undergoing elective cesarean sections will be randomized into three groups using a random allocation table. Group assignment will be performed by opening a previously prepared numbered opaque envelope containing the assignment. Each group will receive the same combined spinal epidural (CSE) containing 10-12mg hyperbaric bupivacaine, 150mcg preservative-free morphine, and 15mcg fentanyl. At surgical closure, Group 1 will receive 10cc bupivacaine 0.0625%, Group 2 will receive 10cc bupivacaine 0.0625% +4mg dexamethasone, and Group 3 will receive 10cc bupivacaine 0.0625% + 8mg dexamethasone (4mg). In order to maintain this as a double-blinded study, the patient will not be told which medication was administered and the drug will be given by one anesthesiologist and the patient follow-up will be performed by a different anesthesiologist. VAS, sedation, nausea, and satisfaction scoring will be measured on patient follow-up to compare how these outcomes compare between the different treatment groups.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Parturients in their 3rd trimester who are receiving a planned cesarean delivery
  • Primiparous and multiparous pregnancies
  • American Society of Anesthesia (ASA) classes 1, 2 , and 3
Exclusion Criteria
  • Patients for whom neuraxial anesthesia was either declined, unsuccessful, or contraindicated
  • Gestational Diabetics
  • Diabetics
  • Patients allergic to dexamethasone, local anesthetics, or opioids
  • Patients that are immunosuppressed
  • Patient who received systemic steroids within the preceding 48 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low DoseDexamethasone4mg Dexamethasone + 10cc 0.0625% bupivacaine
PlaceboDexamethasone10cc 0.0625% bupivacaine
Higher DoseDexamethasone8mg Dexamethasone + 10cc 0.0625% bupivacaine
Primary Outcome Measures
NameTimeMethod
Pain Scoresup to 48 hours post-op

Visual Analog Scale for Pain, uses the Wong-Baker method of presenting faces with different reactions to pain and scales the patient based on the patient selection of a face. The range goes from 0-10. 0 is pain-free and 10 is excruciating pain.

Secondary Outcome Measures
NameTimeMethod
Sedation Scoreup to 48 hours post-op

Richmond Agitation and Sedation Scale (RASS). Its a well known and utilized scale that gradates a patients level of sedation based on various responses to stimuli. The Score goes from -4 to +5. -4 represents a combative and violent patient and +5 represents a patient unresponsive to physical stimuli.

Satisfaction Scoreup to 48 hours post-op

Customer Satisfaction score (CSAT) is a scoring system that scores satisfaction on a 1-5 basis. 1 is very unsatisfied and 5 is very satisfied.

Nausea/ Vomiting Scaleup to 48 hours post-op

Baxter Retching Faces. (BARF) pictorial faces of someone wrenching that is used to scale a patient nausea and vomiting. The range goes from 0-10. 0 is nausea-free and 10 is intractable nausea and vomiting.

Pruritus Scoreup to 48 hours post-op

Pruritus Scale is also a visual analog scale that has a patient rate their discomfort on a number line that gradates the severity.

Motor Functionup to 48 hours post-op

Bromage scale is a scoring system that assesses lower extremity motor function based on ones ability to flex and extend various parts of the leg. Score is 1-4. 1 is no motor block and 4 is complete motor block.

Trial Locations

Locations (1)

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath